Asia Pacific Infant Incubator Market

APAC Infant Incubator Market size (2023 to 2028)

The size of the Infant Incubator Market in the Asia Pacific is estimated to increase at a healthy CAGR from 2023 to 2028.

The infant incubator is a biomedical device with a box-shaped chamber, which provides humidity, heat, and oxygen to the newborn in a controlled environment. An infant incubator improves infant survival rate by maintaining thermal stability in the room and giving the baby an infection-free environment.

The increasing cases of premature babies with lower birth weight and other defects are the factors that contribute to the growth of the infant incubator market. For instance, according to the WHO, around 17 million babies are born prematurely (before 36 weeks gestation) each year. The ever-expanding facilities of the NICU units and the growing awareness of neonatal care are additional factors driving the growth of the Infant Incubator market. The primary driver for the infant incubator market's development is the increasing incidence of preterm birth rates. The growth in the number of NICU admissions and the influx of state-of-the-art infant incubators have further accelerated the demand for infant incubators regionally to initiate appropriate treatment of infants as soon as possible. Funding from government and private sectors to improve neonatal care facilities in upcoming economies is anticipated to provide profitable growth opportunities for the APAC infant incubator market.

However, the global shortage of NICU units and the inflated cost of infant incubators hamper the market growth.

This research report on the Asia Pacific infant incubator market has been segmented and sub-segmented into the following categories:

• By Product: Transport Infant Incubator and Neonatal Intensive Care Unit (NICU) Incubator
• By Application: Neonatal Hypothermia, Lower Birth Weight, Genetic Defects and Others
• By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore, and Rest of APAC

Regionally, the Asia Pacific market leads globally, as far as the growth rate is considered because of the rapid expansion of the medical sector.

The Japanese market is reportedly dominating the neonatal intensive care unit infant incubator market Asia-Pacific by 2028, at a CAGR of 4.7% over the forecast period.

The Chinese market is expected to experience a CAGR of 9.2% in (2023-2028). Furthermore, the Indian market is expected to experience a CAGR of 8.4% in (2023-2028). The Neonatal Intensive Care Unit (NICU) Incubator market dominated the Asia-Pacific infant incubator market by product in 2023, reaching a market value of $ 96.4 million by 2028, during the forecast period. The Transportation Infant Incubator Market is expected to experience the highest CAGR of 9.4% during (2023-2028). In 2022, Asia-Pacific accounted for about a quarter of the global market, which is expected to continue. It is due to the increased adoption of baby incubation technologies and the high incidence of premature babies, especially in China, India, and other developing economies. Besides, the increased investment for the development of Health Information Technology (HCIT) by key players in the field of infant incubators is the main reason for the growth of the market in the Asia-Pacific region.

Prominent companies dominating the Asia Pacific Infant Incubator Market profiled in this report are GE Healthcare, Novos Medical Systems, Atom Medical Corporation, Ningbo David Medical Device Co., Ltd, Natus Medical Incorporated, Fanem Ltd, Cobams Srl, AVI Healthcare Private Limited, Gammer International, and Ardo.